Acta Pharmacologica Sinica Impact Factor IF 2021|2020|2019 ...
www.bioxbio.com › journal › ACTA-PHARMACOL-SINAbout Acta Pharmacologica Sinica. APS, China"s leading journal in pharmacology, encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, ...
Home - Acta Pharmacologica Sinica
www.chinaphar.comThe new Impact Factor of Acta Pharmacologica Sinica (APS) is 6.15 and the Total Cites is 12410 according to the Journal Citation Reports by Clarivate Analytics. The Impact Factor ranking of APS has been promoted to a new record in the Pharmacology & Pharmacy journals (30/275, Q1) and the Multidisciplinary Chemistry journals (45/179, Q2). Read More>>.
Announcements - Acta Pharmacologica Sinica
www.chinaphar.com/announcement11.01.2022 · APS (Acta Pharmacologica Sinica), published monthly in English, is an international peer-reviewed journal. Posted: 2020-07-02 New Impact Factor of APS rose to 5.064 The new Impact Factor of Acta Pharmacologica Sinica (APS) is 5.064 and the Total Cites is 9668 according to the Journal Citation Reports released June 29 by Clarivate Analytics.